• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
International Journal of Cancer and Biomedical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Issue Issue 3
Issue Issue 2
Issue Special Issue
Issue Issue 1
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Saad, M., Elsalamony, R. (2020). Measles vaccines may provide partial protection against COVID-19. International Journal of Cancer and Biomedical Research, 4(Special Issue), 15-19. doi: 10.21608/jcbr.2020.26765.1024
Mahmoud E. Saad; Rokaya A. Elsalamony. "Measles vaccines may provide partial protection against COVID-19". International Journal of Cancer and Biomedical Research, 4, Special Issue, 2020, 15-19. doi: 10.21608/jcbr.2020.26765.1024
Saad, M., Elsalamony, R. (2020). 'Measles vaccines may provide partial protection against COVID-19', International Journal of Cancer and Biomedical Research, 4(Special Issue), pp. 15-19. doi: 10.21608/jcbr.2020.26765.1024
Saad, M., Elsalamony, R. Measles vaccines may provide partial protection against COVID-19. International Journal of Cancer and Biomedical Research, 2020; 4(Special Issue): 15-19. doi: 10.21608/jcbr.2020.26765.1024

Measles vaccines may provide partial protection against COVID-19

Editorial, Volume 4, Special Issue, Spring 2020, Page 15-19  XML PDF (1.45 MB)
DOI: 10.21608/jcbr.2020.26765.1024
Authors
Mahmoud E. Saad email 1; Rokaya A. Elsalamony2
1Chemistry Department, Faculty of Science, Menoufia University, Menoufia, Egypt
2Biochemistry Department, Faculty of Science, Mansoura University, Egypt
Abstract
In December 2019 a new coronavirus COVID-19 was identified in China then spread all over the world. WHO defined China and Italy as the epicenters for COVID-19. Insufficient vaccine coverage has been identified as a key causative factor in the most epidemic outbreaks. Vaccines generally raise specific immune responses to a targeted pathogen, but measles vaccines have recently proved the increased ability of the immune system to fight off pathogens other than measles. COVID-19 is proven to have similarities with measles. Such similarities may cause cross-reactivity between measles vaccines and COVID-19. For instance, comparing China and Italy for COVID-19 case and the death rates from late 2019 until Mars 25, 2020, Italy showed higher ratio of COVID-19 cases/population and a higher death rate than China. In contrast, Italy showed lower measles vaccination coverage than China. In this review, we hypothesized that the bystander immunity induced by measles vaccines may provide partial protection against COVID-19, decreasing the virus’s ability to cause fatal symptoms and controlling the infection leading to full recovery. Accordingly, we suggest multi-center clinical trials to evaluate the possibility of induced partial protection by measles-containing vaccines against COVID-19.
Keywords
Coronaviruses; COVID-19; Measles vaccine; Cross reactivity; MMR
Statistics
Article View: 12,553
PDF Download: 1,928
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.